BUSINESS● LOWAug 14 · Aug 14, 2026, 11:03 AM
Tvardi Therapeutics GAAP EPS of -$0.69 misses by $0.06
Seeking Alpha Tech
Tvardi Therapeutics reported a GAAP EPS of -$0.69, which missed expectations by $0.06. This indicates the company's financial performance did not meet analysts' projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS19m agoGalleon Gold increases bought deal private placement of shares to $27MSeeking Alpha TechBUSINESS22m agoTech stocks had a nice oversold bounce on Monday. Earnings this week will determine if it's for realCNBC